Cocrystal Pharma Inc (COCP) Stock Analysis

Cocrystal Pharma Inc (COCP) is a publicly traded company in the HEALTHCARE sector. It trades at $1.05, carries a market capitalization of $15.30M. This page summarizes the public market data, fundamentals, and frequently asked questions for COCP, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Cocrystal Pharma Inc currently has a Bullish sentiment score of 0.34.

About Cocrystal Pharma Inc

Cocrystal Pharma, Inc. (COCP) is a forward-thinking biotechnology company specializing in the development of antiviral therapies for serious and chronic viral infections. Positioned in Bothell, Washington, the company utilizes cutting-edge technologies to innovate and advance its proprietary drug candidates, aiming to meet significant unmet medical needs within the antiviral realm. With a solid research foundation, Cocrystal Pharma is committed to transforming treatment paradigms and enhancin...

GNG Research Analysis

GNG Research scores Cocrystal Pharma Inc (COCP) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for COCP.

Frequently Asked Questions

Does COCP pay dividends?

Cocrystal Pharma Inc (COCP) does not currently pay a regular dividend.

What is COCP's market cap?

Cocrystal Pharma Inc (COCP) has a market capitalization of $15.30M with a current stock price of $1.05.